股票期权激励计划
Search documents
乐心医疗: 第四届董事会第二十四次会议决议公告
Zheng Quan Zhi Xing· 2025-05-23 10:43
证券代码:300562 证券简称:乐心医疗 公告编号:2025-045 广东乐心医疗电子股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 乐心医疗 2025 年公告 一、董事会会议召开情况 十四次会议于 2025 年 05 月 16 日以电子邮件、电话、专人送达等方式通知全体 董事,会议于 2025 年 05 月 22 日以线上方式召开。 公司全体高级管理人员列席了本次会议。 《公司章程》有关规定,表决形成的决议合法、有效。 二、董事会会议审议情况 本次会议以书面记名投票方式进行表决,经与会董事认真审议通过以下决议: 选人的议案》 公司第四届董事会任期即将届满,根据《公司法》《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规以及《公司章 程》的有关规定,公司按照相关程序进行董事会换届选举,提名潘伟潮先生、潘 志刚先生、梁华权先生为公司第五届董事会非独立董事候选人,任期自公司股东 会审议通过之日起三年。现对下列候选人提名议案逐项审议: (1)《关于提名潘伟潮先生为第五届董事会非独立董事候选人的议案》 表决结果:同意 ...
科力远: 科力远监事会关于2025年股票期权激励计划首次授予激励对象名单的核查意见
Zheng Quan Zhi Xing· 2025-05-23 10:43
(三)获授股票期权的激励对象符合《公司法》、《证券法》等法律、法规、 规范性文件以及《公司章程》规定的任职资格,符合《管理办法》等法律、法规 和规范性文件规定的激励对象条件,符合公司《2025 年股票期权激励计划(草 案)》及其摘要规定的激励对象范围。 湖南科力远新能源股份有限公司监事会 综上,监事会一致同意董事会确定本激励计划的首次授予日为 2025 年 5 月 湖南科力远新能源股份有限公司监事会 或者采取市场禁入措施; (二)获授股票期权的激励对象包括公司(含分、子公司)董事、高级管理 人员以及董事会认为应当激励的其他人员,符合实施股权激励计划的目的。激励 对象中不包括公司独立董事、监事,也不包括单独或合计持有公司 5%以上股份 的股东或实际控制人及其配偶、父母、子女。 关于 2025 年股票期权激励计划首次授予激励对象名单的核查意见 湖南科力远新能源股份有限公司(以下简称"公司")监事会依据《中华人 民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》(以 下简称"《证券法》")、《上市公司股权激励管理办法》(以下简称"《管理 办法》")等有关法律、法规和规范性文件以及《公司章程》的规定 ...
老板电器: 上海荣正企业咨询服务(集团)股份有限公司关于杭州老板电器股份有限公司2025年股票期权激励计划授予事项之独立财务顾问报告
Zheng Quan Zhi Xing· 2025-05-23 09:21
Core Viewpoint - The independent financial advisor report indicates that the stock option incentive plan for 2025 at Boss Electric has received necessary approvals and is in compliance with relevant regulations and company policies [5][8]. Group 1: Incentive Plan Overview - The 2025 stock option incentive plan includes proposals for the authorization and approval of the plan, as well as the management measures for its implementation [3][4]. - The plan aims to incentivize core technical and business personnel, with a total of 608,000 stock options allocated, representing 0.64% of the company's current share capital [6]. Group 2: Approval and Compliance - The report confirms that the stock option grant has been approved by the board and aligns with the conditions set forth in the 2024 annual shareholders' meeting [7]. - The grant date for the stock options is set for May 23, 2025, which complies with the stipulated regulations [7]. Group 3: Financial Impact and Conditions - The financial advisor emphasizes the importance of accurately reflecting the impact of the stock option incentive plan on the company's financial status and operating results, adhering to accounting standards [8]. - The report states that the conditions for granting stock options have been met, and there are no circumstances that would harm the interests of the company or its shareholders [8].
老板电器: 关于向激励对象授予股票期权的公告
Zheng Quan Zhi Xing· 2025-05-23 09:20
Core Viewpoint - The company has approved a stock option incentive plan, granting 6.08 million stock options to 372 eligible participants, effective from May 23, 2025, as part of its 2025 stock option incentive plan [1][2][3] Summary by Sections Stock Option Incentive Plan Approval - The company held meetings on May 23, 2025, where the stock option incentive plan was approved by the board and supervisory committee [1][2] - The plan was previously disclosed on April 29, 2025, and included the names and positions of the incentive recipients [2] Details of the Stock Option Grant - A total of 6.08 million stock options will be granted, representing 0.64% of the company's current total share capital [3][8] - The plan excludes independent directors, supervisors, and shareholders holding more than 5% of the company's shares [8] Vesting and Exercise Conditions - The stock options have a maximum validity of 48 months from the grant date, with a waiting period of 12, 24, and 36 months for different tranches [4][5] - The exercise periods are divided into three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months [5] Performance Assessment Criteria - The performance assessment for the stock options will be based on net asset return rates and revenue growth compared to industry averages for the years 2025 to 2027 [6][7] - If the company fails to meet the performance targets, the stock options for that year will be canceled [6] Financial Implications - The funds raised from the stock option exercise will be used to supplement the company's working capital [8] - The company will not provide any financial assistance for the exercise of stock options, and all taxes will be withheld as per regulations [8] Legal and Compliance - The plan has received necessary approvals and complies with relevant laws and regulations, ensuring no conflicts with shareholder interests [11][12]
森马服饰: 关于部分股票期权注销完成的公告
Zheng Quan Zhi Xing· 2025-05-23 08:22
Core Points - The company announced the cancellation of 39,145,520 stock options due to the failure to meet the exercise conditions for the first exercise period of the 2024 stock option incentive plan [1][2] - The cancellation was approved at the company's annual general meeting held on May 8, 2025, and completed on May 23, 2025 [2] - The cancellation process complies with relevant laws and regulations, ensuring no adverse effects on the company's capital structure or the interests of shareholders, particularly minority shareholders [2] Summary by Sections - **Stock Option Cancellation**: The company canceled a total of 39,145,520 stock options, which includes 38,725,320 options from 143 incentive targets who did not meet the exercise conditions and 420,200 options from a departing employee [1] - **Approval and Completion**: The cancellation was approved during the shareholder meeting on May 8, 2025, and was finalized by the China Securities Depository and Clearing Corporation on May 23, 2025 [2] - **Regulatory Compliance**: The cancellation adheres to the company's stock option incentive plan and relevant regulatory guidelines, confirming that the reasons and quantities for cancellation are legal and valid [2]
瑞丰光电: 关于2024年股票期权与限制性股票激励计划部分股票期权注销完成的公告
Zheng Quan Zhi Xing· 2025-05-22 11:10
Core Viewpoint - Shenzhen Ruifeng Optoelectronics Co., Ltd. has completed the cancellation of a total of 1.7464 million stock options as part of its 2024 stock option and restricted stock incentive plan due to various reasons including employee departures and performance assessments [1][2]. Group 1: Stock Option Cancellation - The company held a board meeting on April 23, 2025, where it approved the cancellation of stock options for employees who no longer qualify as incentive targets due to resignation or other reasons [1]. - A total of 1.715 million stock options will be canceled due to 36 employees leaving the company for personal reasons, which disqualifies them from exercising their options [1]. - Additionally, 3.14 thousand stock options will be canceled for 4 employees whose performance assessments did not meet the required standards, with two achieving a "B" rating (80% exercisable) and two a "C" rating (60% exercisable) [2]. Group 2: Legal and Administrative Procedures - The company has obtained a legal opinion regarding the cancellation of stock options and has submitted the necessary application to the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, for the cancellation process [2]. - The cancellation of the stock options was confirmed and completed on May 22, 2025, and will not affect the company's share capital as these options had not been exercised [2].
北京万东医疗科技股份有限公司 第十届监事会第八次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-21 23:49
Group 1 - The company held the eighth meeting of the tenth Supervisory Board on May 21, 2025, and approved the adjustment of the 2025 stock option incentive plan, including the list of incentive objects, the number of options granted, and the exercise price [1][3][72] - The meeting was attended by all three supervisors, and the resolutions were passed unanimously [2][4][6] - The company plans to cancel the Supervisory Board and amend the Articles of Association, which will be submitted for shareholder approval [5][7][84] Group 2 - The company announced the resignation of Chairman Hu Ziqiang due to personal reasons, effective immediately, and expressed gratitude for his contributions [10][11] - Ma Chibing was elected as the new Chairman of the Board on May 21, 2025, with a term lasting until the end of the current Board's tenure [12][42] Group 3 - The company will grant 9.6 million stock options to 85 eligible incentive objects, with an exercise price of 15.05 yuan per option, effective from May 21, 2025 [13][14][25] - The initial number of options was adjusted from 10.8 million due to the departure of two incentive objects [76][79] - The stock option incentive plan has undergone necessary approvals and complies with relevant regulations [39][81][82] Group 4 - The company will not set up a Supervisory Board, transferring its responsibilities to the Audit Committee of the Board to enhance governance [84] - The Articles of Association will be revised to reflect this change and other necessary updates [85]
赛微微电: 关于2020年股票期权激励计划首次授予第四个行权期行权结果暨股份变动公告
Zheng Quan Zhi Xing· 2025-05-21 12:13
证券代码:688325 证券简称:赛微微电 公告编号:2025-039 广东赛微微电子股份有限公司 关于 2020 年股票期权激励计划首次授予第四个行权期行权结 果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、本次股票期权行权的决策程序及相关信息披露 限")召开了董事会,审议通过了《关于公司 2020 年度期权激励计划(草案)的议 案》《关于公司 2020 年度期权激励计划实施考核管理办法的议案》《关于提请股东 会授权董事会办理公司 2020 年度期权激励相关事宜的议案》,关联董事均回避表决。 同日,赛微有限监事决定审议通过了《2020 年度期权激励计划(草案)》,同意公 司本次激励计划,认为本次激励计划的实施有利于公司的可持续发展,不存在损害 公司及全体股东利益的情形;并发表了监事对 2020 年度期权激励计划激励对象名单 的核查意见。 期权激励计划(草案)的议案》《关于公司 2020 年度期权激励计划实施考核管理办 法的议案》《关于提请股东会授权董事会办理公司 2020 年度期权激 ...
菲沃泰: 关于2025年股票期权激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Zheng Quan Zhi Xing· 2025-05-21 12:00
Core Viewpoint - The company conducted a self-examination regarding the stock trading activities of insiders and incentive recipients related to the 2025 stock option incentive plan, confirming no insider trading occurred during the specified period [1][3]. Group 1: Announcement of the Incentive Plan - The company held meetings on April 29, 2025, to approve the draft of the 2025 stock option incentive plan and disclosed the relevant announcements on April 30, 2025 [1]. - The company ensured compliance with various regulations and internal policies regarding the confidentiality of the incentive plan [2]. Group 2: Self-Examination Process - The self-examination covered the trading activities of insiders and incentive recipients within six months prior to the public disclosure of the incentive plan [2]. - The company submitted a query to the China Securities Depository and Clearing Corporation Limited Shanghai Branch to verify the stock trading activities of the identified individuals [3]. Group 3: Findings and Conclusion - The examination revealed that none of the insiders or incentive recipients engaged in buying or selling the company's stock during the self-examination period [3]. - The company confirmed that all actions taken by the involved parties complied with relevant regulations, and no insider information was leaked or misused [3].
*ST京蓝: 关于2024年股票期权激励计划第一个行权期行权条件成就的公告
Zheng Quan Zhi Xing· 2025-05-21 12:00
Core Viewpoint - The announcement details the achievement of the first exercise conditions for the 2024 stock option incentive plan of Jinglan Technology Co., Ltd, allowing 49 eligible participants to exercise a total of 109.475 million stock options at a price of 1.83 yuan per share [1][2][14]. Summary by Sections Stock Option Incentive Plan - The stock option incentive plan was approved by the board on May 5, 2025, confirming that the conditions for the first exercise period have been met [1][14]. - A total of 10,947.5 million stock options are available for exercise by 49 eligible participants [1][14]. Procedures and Approvals - The plan underwent necessary procedures, including reviews by the remuneration and assessment committee and independent directors, prior to approval by the shareholders' meeting [1][2]. - Adjustments were made to the plan, including the number of participants and stock options due to some participants opting out [2][10]. Performance Assessment - The performance assessment for the stock options is based on the company's revenue and net profit for the years 2024 and 2025, with specific targets set for each year [9][10]. - The exercise conditions include the absence of negative audit opinions and compliance with legal regulations [5][8]. Impact on Financials - If all options are exercised, the total share capital will increase from 2,856.976 million shares to 2,966.451 million shares, potentially diluting earnings per share and return on equity [14]. - The company has chosen the Black-Scholes model to determine the fair value of the stock options at the grant date [14]. Legal and Compliance - Legal opinions confirm that the necessary approvals and authorizations for the exercise of stock options have been obtained, and the company must fulfill its disclosure obligations [15].